rabbit anti irf1 polyclonal antibody (Proteintech)
Structured Review

Rabbit Anti Irf1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+irf1+polyclonal+antibody/pmc09468581-125-0-9?v=Proteintech
Average 95 stars, based on 61 article reviews
Images
1) Product Images from "Toosendanin suppresses African swine fever virus replication through upregulating interferon regulatory factor 1 in porcine alveolar macrophage cultures"
Article Title: Toosendanin suppresses African swine fever virus replication through upregulating interferon regulatory factor 1 in porcine alveolar macrophage cultures
Journal: Frontiers in Microbiology
doi: 10.3389/fmicb.2022.970501
Figure Legend Snippet: The primers used for determining the mRNA level of 9 ISGs and IFNs by qRT-PCR.
Techniques Used: Sequencing
Figure Legend Snippet: Three pairs of siRNAs designed to silence the endogenous IRF1.
Techniques Used: Sequencing
Figure Legend Snippet: Effects of TSN on the mRNA expression of IFNs and 9 ISGs in PAMs. 0.014 MOI ASFV infected the PAMs for 24 h to test its effect on the expression level of IFNs (IFNα, IFNβ and IFNγ) and 9 ISGs (TRIM26, IRF1, SAT1, ISG20, GBP1, PKR, MX1, DCP1A and SHFL). Besides, 1 μM TSN was added to PAMs with or without ASFV infection (0.014 MOI) for 24 h to test its effect on the expression of IFNs (IFNα, IFNβ and IFNγ) and 9 ISGs (TRIM26, IRF1, SAT1, ISG20, GBP1, PKR, MX1, DCP1A and SHFL). The vertical axis shows the relative expression level (fold-change) of IFNs or 9 ISGs mRNA. The fold-changes were calculated by the 2 ∆∆CT method and normalized by IFNβ level (A,C,E) or TRIM26 level (B,D,F) in mock or ASFV group. (A) The mRNA level of IFNα, IFNβ and IFNγ in PAMs with ASFV infection was analyzed using RT-qPCR. (B) The mRNA level of 9 ISGs in PAMs with ASFV infection was analyzed using RT-qPCR. (C) The mRNA levels of IFNα, IFNβ and IFNγ in PAMs with or without TSN treatment were analyzed using RT-qPCR. (D) The mRNA levels of 9 ISGs in PAMs with or without TSN treatment were analyzed using RT-qPCR. (E) The mRNA levels of IFNα, IFNβ and IFNγ in ASFV-infected PAMs with or without TSN treatment were analyzed using RT-qPCR. (F) The mRNA levels of 9 ISGs in ASFV-infected PAMs with or without TSN treatment were analyzed using RT-qPCR. *** denotes p < 0.001; ** denotes p < 0.01; * denotes p < 0.05; ns denotes not significant.
Techniques Used: Expressing, Infection, Quantitative RT-PCR
Figure Legend Snippet: TSN treatment upregulates the mRNA expressions of IFNs and IRF1, and the protein expression of IRF1 in PAMs. 0.014 MOI ASFV infected the PAMs for 6, 12, and 24 h to test its effect on the expression level of IFNs (IFNα, IFNβ and IFNγ) and IRF1. Besides, 1 μM TSN was added to PAMs with or without ASFV infection (0.014 MOI) for 6, 12, and 24 h to test its effect on the expression levels of IFNs (IFNα, IFNβ and IFNγ) and IRF1. The vertical axis shows the relative expression level (fold-change) of IFNs or IRF1 mRNA. The fold-changes were calculated by the 2 ∆∆CT method and normalized by IFNβ or IRF1 levels at 24 h in mock or ASFV group. (A) The mRNA levels of IFNα, IFNβ and IFNγ in PAMs with ASFV infection at 6, 12, and 24 h was analyzed using RT-qPCR. (B) The mRNA level of IRF1 in PAMs with ASFV infection at 6, 12, and 24 h was analyzed using RT-qPCR. (C) The protein level of IRF1 in PAMs with ASFV infection at 6, 12, and 24 h was analyzed using Western Blot. (D) The mRNA levels of IFNα, IFNβ and IFNγ in PAMs with or without TSN treatment at 6, 12, and 24 h was analyzed using RT-qPCR. (E) The mRNA level of IRF1 in PAMs with or without TSN treatment at 6, 12, and 24 h was analyzed using RT-qPCR. (F) The protein level of IRF1 in PAMs with or without TSN treatment at 6, 12, and 24 h was analyzed using Western Blot. (G) The mRNA levels of IFNα, IFNβ and IFNγ in ASFV-infected PAMs with or without TSN treatment at 6, 12, and 24 h was analyzed using RT-qPCR. (H) The mRNA level of IRF1 in ASFV-infected PAMs with or without TSN treatment at 6, 12, and 24 h was analyzed using RT-qPCR. (I) The protein level of IRF1 in ASFV-infected PAMs with or without TSN treatment at 6, 12, and 24 h was analyzed using Western Blot. *** denotes p < 0.001; ** denotes p < 0.01; * denotes p < 0.05; ns denotes not significant.
Techniques Used: Expressing, Infection, Quantitative RT-PCR, Western Blot
Figure Legend Snippet: TSN suppresses ASFV replication via upregulating IRF1 expression. (A) PK-15 cells were challenged with 0.014 MOI ASFV at 37°C for 2 h, then PRK5-FLAG-IRF1 was transfected into PK15 cells at 37°C for 6 h. After that, the supernatant was discarded and the cells were washed with PBS. Then fresh maintenance medium was added in PK-15 cells and incubated at 37°C for 16 h. The samples were harvested at 16 h post transfection for Western Blot. (B) PAMs were transfected with 2 μg/ml of three different siRNA against IRF1 and scramble siRNA (siRNA-Scra) at 37°C for 4 h. After that, the supernatant was discarded and the cells were washed with PBS, then fresh maintenance medium was added in PAMs. IRF1 was detected by RT-qPCR at 24 h post siRNA transfection. (C) PAMs were challenged with 0.014 MOI ASFV at 37°C for 2 h, then the siRNA-IRF1-301 or siRNA-Scra was transfected into PAMs at 37°C for 6 h. After that, the supernatant was discarded and the cells were washed with PBS followed by treatment with 1 μM TSN. After culture at 37°C for 16 h, the samples were collected for Western Blot. (D) The samples from panel (C) were collected for endpoint dilution method analysis. *** denotes p < 0.001; ** denotes p < 0.01; * denotes p < 0.05. ns denotes no significant difference.
Techniques Used: Expressing, Transfection, Incubation, Western Blot, Quantitative RT-PCR
